• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia.与急性髓系白血病中组合性表观遗传功能获得相关的突变协同作用
Cancer Cell. 2015 Apr 13;27(4):502-15. doi: 10.1016/j.ccell.2015.03.009.
2
[Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with Mutations].[急性髓系白血病患者共突变基因的临床特征及预后相关性研究]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1032-1038. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.009.
3
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in - and -Mutant Acute Myeloid Leukemia.联合靶向治疗以破坏异常致癌信号并逆转NPM1 -和FLT3 -突变急性髓系白血病中的表观遗传功能障碍
Cancer Discov. 2017 May;7(5):494-505. doi: 10.1158/2159-8290.CD-16-1049. Epub 2017 Feb 13.
4
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.正常核型急性髓系白血病基因突变的治疗靶点展望
Br J Haematol. 2015 Aug;170(3):305-22. doi: 10.1111/bjh.13409. Epub 2015 Apr 19.
5
DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.DNMT3A单倍体不足将FLT3ITD骨髓增殖性疾病转化为快速、自发且完全显性的急性髓系白血病。
Cancer Discov. 2016 May;6(5):501-15. doi: 10.1158/2159-8290.CD-16-0008. Epub 2016 Mar 25.
6
MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.微小RNA-155作为急性髓系白血病中细胞凋亡和细胞分化的诱导剂
Mol Cancer. 2014 Apr 5;13:79. doi: 10.1186/1476-4598-13-79.
7
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.联合使用 STAT5 抑制剂 AC-4-130 和 MCL1 抑制剂 S63845 治疗 FLT3 突变或 TET2 突变急性髓系白血病的理由。
Int J Mol Sci. 2021 Jul 28;22(15):8092. doi: 10.3390/ijms22158092.
8
Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors.磷酸化蛋白质组分析揭示了 Hcls1、p21 激活激酶 1 和 Ezrin 在野生型和 ITD 突变 Fms 样酪氨酸激酶 3 受体下游髓样祖细胞系增殖中的特定作用。
J Proteomics. 2013 Jan 14;78:231-44. doi: 10.1016/j.jprot.2012.09.009. Epub 2012 Sep 24.
9
CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.细胞周期蛋白磷酸酶25A(CDC25A)调控FLT3内部串联重复急性髓系白血病的增殖与分化。
Oncotarget. 2015 Nov 10;6(35):38061-78. doi: 10.18632/oncotarget.5706.
10
Molecular pathogenesis of AML: translating insights to the clinic.急性髓系白血病的分子发病机制:将研究进展转化为临床实践。
Best Pract Res Clin Haematol. 2013 Sep;26(3):245-8. doi: 10.1016/j.beha.2013.10.003. Epub 2013 Oct 15.

引用本文的文献

1
Cell Settling, Migration, and Stochastic Cancer Gene Expression Suggest Potassium Membrane Flux May Initiate pH Reversal.细胞沉降、迁移和随机癌症基因表达表明钾离子膜通量可能引发pH值逆转。
Biomolecules. 2025 Aug 16;15(8):1177. doi: 10.3390/biom15081177.
2
Epigenetic regulation of cancer stemness.癌症干性的表观遗传调控。
Signal Transduct Target Ther. 2025 Aug 1;10(1):243. doi: 10.1038/s41392-025-02340-6.
3
Joint representation and visualization of derailed cell states with Decipher.使用Decipher对脱轨细胞状态进行联合表示和可视化。
Genome Biol. 2025 Jul 23;26(1):219. doi: 10.1186/s13059-025-03682-8.
4
Direct genetic transformation bypasses tumor-associated DNA methylation alterations.直接基因转化绕过了肿瘤相关的DNA甲基化改变。
Genome Biol. 2025 Jul 17;26(1):212. doi: 10.1186/s13059-025-03650-2.
5
Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia.核黄素驱动核苷酸生物合成和铁硫代谢以促进急性髓系白血病。
bioRxiv. 2025 Jun 29:2025.06.26.661633. doi: 10.1101/2025.06.26.661633.
6
Mutant cooperates with or to drive distinct myeloid diseases and molecular outcomes.突变体协同或驱动不同的髓系疾病及分子结果。
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2415779122. doi: 10.1073/pnas.2415779122. Epub 2025 May 16.
7
The physiological functions of ascorbate in the development of cancer.抗坏血酸盐在癌症发展中的生理功能。
Dis Model Mech. 2025 Apr 1;18(4). doi: 10.1242/dmm.052201. Epub 2025 Apr 11.
8
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment.TP53突变与TET2缺陷协同作用,驱动白血病发生并建立免疫抑制环境。
J Clin Invest. 2025 Mar 20;135(10). doi: 10.1172/JCI184021. eCollection 2025 May 15.
9
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.GATA2将急性髓系白血病的干性与化疗耐药性联系起来。
Blood. 2025 May 8;145(19):2179-2195. doi: 10.1182/blood.2024025761.
10
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.IRE1α-XBP1通过限制促白血病基因程序来保护造血干细胞和祖细胞。
Nat Immunol. 2025 Feb;26(2):200-214. doi: 10.1038/s41590-024-02063-w. Epub 2025 Jan 9.

本文引用的文献

1
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.DNA羟甲基化分析表明,WT1突变导致急性髓系白血病中TET2功能丧失。
Cell Rep. 2014 Dec 11;9(5):1841-1855. doi: 10.1016/j.celrep.2014.11.004. Epub 2014 Dec 4.
2
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.
3
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
4
Age-related mutations associated with clonal hematopoietic expansion and malignancies.与克隆性造血扩张和恶性肿瘤相关的年龄相关突变。
Nat Med. 2014 Dec;20(12):1472-8. doi: 10.1038/nm.3733. Epub 2014 Oct 19.
5
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.TET2突变可预测骨髓增生异常综合征患者对去甲基化药物的反应。
Blood. 2014 Oct 23;124(17):2705-12. doi: 10.1182/blood-2014-06-582809. Epub 2014 Sep 15.
6
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.单一癌基因增强子重排导致白血病中 EVI1 和 GATA2 的同时失调。
Cell. 2014 Apr 10;157(2):369-381. doi: 10.1016/j.cell.2014.02.019. Epub 2014 Apr 3.
7
Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.GATA2 的表观遗传调控及其对正常核型急性髓系白血病的影响。
Leukemia. 2014 Aug;28(8):1617-26. doi: 10.1038/leu.2014.67. Epub 2014 Feb 11.
8
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.突变型异柠檬酸脱氢酶2(IDH2)在白血病起始和维持中的原癌基因作用
Cell Stem Cell. 2014 Mar 6;14(3):329-41. doi: 10.1016/j.stem.2013.12.016. Epub 2014 Jan 16.
9
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.基因调控区域的羟甲基化指导了红细胞生成过程中干细胞/早期祖细胞的定向分化。
Cell Rep. 2014 Jan 16;6(1):231-244. doi: 10.1016/j.celrep.2013.11.044. Epub 2013 Dec 27.
10
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.分子突变对骨髓增生异常综合征及相关肿瘤中 DNMT 抑制剂治疗反应的影响。
Leukemia. 2014 Jan;28(1):78-87. doi: 10.1038/leu.2013.269. Epub 2013 Sep 18.

与急性髓系白血病中组合性表观遗传功能获得相关的突变协同作用

Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia.

作者信息

Shih Alan H, Jiang Yanwen, Meydan Cem, Shank Kaitlyn, Pandey Suveg, Barreyro Laura, Antony-Debre Ileana, Viale Agnes, Socci Nicholas, Sun Yongming, Robertson Alexander, Cavatore Magali, de Stanchina Elisa, Hricik Todd, Rapaport Franck, Woods Brittany, Wei Chen, Hatlen Megan, Baljevic Muhamed, Nimer Stephen D, Tallman Martin, Paietta Elisabeth, Cimmino Luisa, Aifantis Iannis, Steidl Ulrich, Mason Chris, Melnick Ari, Levine Ross L

机构信息

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Institute for Computational Biomedicine and Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA; Department of Medicine/Hematology-Oncology and Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA.

出版信息

Cancer Cell. 2015 Apr 13;27(4):502-15. doi: 10.1016/j.ccell.2015.03.009.

DOI:10.1016/j.ccell.2015.03.009
PMID:25873173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4518555/
Abstract

Specific combinations of acute myeloid leukemia (AML) disease alleles, including FLT3 and TET2 mutations, confer distinct biologic features and adverse outcome. We generated mice with mutations in Tet2 and Flt3, which resulted in fully penetrant, lethal AML. Multipotent Tet2(-/-);Flt3(ITD) progenitors (LSK CD48(+)CD150(-)) propagate disease in secondary recipients and were refractory to standard AML chemotherapy and FLT3-targeted therapy. Flt3(ITD) mutations and Tet2 loss cooperatively remodeled DNA methylation and gene expression to an extent not seen with either mutant allele alone, including at the Gata2 locus. Re-expression of Gata2 induced differentiation in AML stem cells and attenuated leukemogenesis. TET2 and FLT3 mutations cooperatively induce AML, with a defined leukemia stem cell population characterized by site-specific changes in DNA methylation and gene expression.

摘要

急性髓系白血病(AML)疾病等位基因的特定组合,包括FLT3和TET2突变,具有独特的生物学特征和不良预后。我们构建了Tet2和Flt3发生突变的小鼠,这些小鼠会发生完全显性的致死性AML。多能性Tet2(-/-);Flt3(ITD)祖细胞(LSK CD48(+)CD150(-))可在二次受体中传播疾病,并且对标准AML化疗和FLT3靶向治疗均耐药。Flt3(ITD)突变和Tet2缺失协同重塑DNA甲基化和基因表达,其程度是单独任何一个突变等位基因所未见的,包括在Gata2基因座处。Gata2的重新表达诱导AML干细胞分化并减弱白血病发生。TET2和FLT3突变协同诱导AML,其特定的白血病干细胞群体具有DNA甲基化和基因表达的位点特异性变化特征。